Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
by Richard Daverman, PhD
July 23, 2013 -- Despite its well-publicized problems in China, GlaxoSmithKline is actively moving forward with a plan to form a vaccine collaboration with a China company. The company revealed it is talking to several China vaccine makers, with the goal of forming an R&D/marketing partnership. Christophe Weber, head of GSK’s vaccine division, said the conversations have not been affected by the on-going bribery scandal. More details....
Stock Symbol: (NYSE: GSK)
Help employers find you! Check out all the jobs and post your resume.
